Long-term results of early cyclosporin therapy in juvenile IDDM

Diabetes

Volumn 45, Issue 1, 1996, Pages 101-104

  De Filippo, Gianpaolo ^a   Carel, Jean Claude ^a   Boitard, Christian ^b   Bougnères, Pierre François ^a,c  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CYCLOSPORIN; GLUCAGON; HEMOGLOBIN A1C; INSULIN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GINGIVA HYPERPLASIA; HUMAN; HUMAN TISSUE; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; LONG TERM CARE; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL; PARESTHESIA; PRIORITY JOURNAL; REMISSION;

EID: 0030058792     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.45.1.101     Document Type: Article

References (17)

1. Stiller CR, Dupré J, Gent M. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223 1362-1307. 1984
2. Assan R, Feutren G, Debray-Sachs M, Quiniou-Debrie MC, Labone C, Thomas G, Chatenoud L, Bach JF: Metabolic and immunological effects of cyclosporine in recently diagnosed type I diabetes mellitus. Lancet i:67-71, 1985
3. Feutren G, Papoz L, Assan R, Vialettes B. Karsenty G. Vexiau P. Du Rostu H, Rodier M, Slrmai J, Lallemand A, Bach J-F: Cyclosporine increases the rate and length of remissions in insulin-dependent diabetes of recent onset Lancet i:119-124, 1986
4. Bougnères PF, Carel J-C, Castano L, Boitard C. Gardin JP, Landais P. Hors J. Mihatsch MJ, Paillard M, Chaussain J-L, Bach J-F: Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med 318 663-670, 1988
5. Canadian-European Randomized Control Trial Group: Cyclosponn-induced remission of IDDM after early intervention: association of 1 yr of cyclosporin treatment with enhanced insulin secretion. Diabetes 37: 1574-1582, 1988
6. Assan R, Feutren G, Sirmai J, Laborie C, Boitard C, Vexiau P, Du Rostu H, Rodier M, Figoni M, Vague P, Hors J, Bach J-F. Plasma C-pepride levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin. Diabetes 39:768-774, 1990
7. Bougnères PF, Landais P, Boisson C, Carel J-C, Frament N, Boitard C, Chaussain J-L, Bach JF: Limited duration of the remission of insulin dependency in children with recent overt type I diabetes treated with low dose cyclosporin. Diabetes 39:1264-1272, 1990
8. Bougnères PF, Landais P. Mairesse AM, Jais JP, Jos J, Peyraud J. Wieliczko MC, Chavoix P, Garandeau P, Asensi D, Ythier H, Rouland V, Mazoyer T. Leturcq F, Raynaud E: Improvement of diabetic control and acceptability of a three-injection insulin regimen in diabetic adolescents. Diabetes Care 16:94-102, 1993
9. Boisson-Lesage C: Clinical studies of beta cell function in normal and diabetic children. MD thesis. Pans, Université René Descartes, 1989
10. The Diabetes Control and Complications Trial Research Group: Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual ß-cell function, observations during eligibility testing foi the diabetes control and complications trial (DCCT) J Clin Endocrinol Metab 65 30-36, 1987
11. Feutren G, Mihatsch MJ: Risk factors for cyclosponne-induccd nephropathy in patients with autoimmune diseases N Engl J Med 326; 1664-1670. 1992
12. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 977-986, 1993
13. Daneman D, Tsalikian E, Hengstenberg F, Becker DJ, Drash AL. Glycosylated haemoglobin in children with insulin-dependent diabetes mellitus. Diabctologia 19:423-426, 1980
14. 1, levels in children and adolescents with diabetes mellitus. Diabetes Care 3:503-507,1980
15. Mann NP, Johnston DI: Total glycosylated haemoglobin levels in diabetic children. Arch Dis Child 57:434-437, 1982
16. lc relation to age, duration, C-peptide, insulin dose and one or two insulin injections. Diabetes Care 5:399-403, 1982
17. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV Impaired insulin action in puberty: a contributing farctor to poor glycomic control in adolescents with diabetes N Enyl J Med 315:215-219, 1986